IFP Advisors’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$833 Hold
10
– – ﹤0.01% 4540
2026
Q2
$952 Buy
10
+7
+233% +$466 ﹤0.01% 4510
2026
Q1
$147 Hold
3
– – ﹤0.01% 4674
2025
Q4
$91 Hold
3
– – ﹤0.01% 4611
2025
Q3
$58 Buy
+3
New +$44 ﹤0.01% 4641

Other funds holding ORKA

IFP Advisors's ORKA Position: Q3 2026 in Review

IFP Advisors held its Oruka Therapeutics (ORKA) position steady in Q3 2026 at 10 shares worth $833. The position accounts for ﹤0.01% of the portfolio, ranked #4540.

IFP Advisors first reported a position in ORKA in Q3 2025 and has held it in 5 quarters since. The position peaked at $952 in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • IFP Advisors held 10 shares of Oruka Therapeutics worth $833 as of Q3 2026.
  • IFP Advisors left its Oruka Therapeutics share count unchanged in Q3 2026.
  • Oruka Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4540 holding.
  • IFP Advisors first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • IFP Advisors's Oruka Therapeutics position peaked at $952 in Q2 2026.
  • 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.